Loffeld R J, Werdmuller B F, Kuster J G, Pérez-Pérez G I, Blaser M J, Kuipers E J
Department of Internal Medicine, De Heel Zaans Medisch Centrum Zaandam, The Netherlands.
Digestion. 2000;62(2-3):95-9. doi: 10.1159/000007801.
The hypothesis that colonization with cagA(+) Helicobacter pylori strains protects against the development of gastroesophageal reflux disease (GERD) and its complications is tested.
Patients with reflux esophagitis and Barrett's esophagus were studied. Antral biopsy specimens were obtained for detection of H. pylori. A serum sample was obtained for determination of IgG antibodies to H. pylori and to the CagA protein.
736 patients were studied. 118 patients had reflux esophagitis, 36 had Barrett's esophagus, 108 had hiatal hernia without signs of inflammation (the reflux group), and 20 patients had esophageal or stomach cancer. The remaining 454 patients had no signs of GERD. The 262 patients with reflux disease had a significantly lower prevalence of H. pylori (34.9%) than the 454 controls (54.6%; p<0. 001). Among 310 H. pylori-positive patients from whom serum was available, colonization with cagA(+) strains was detected in 59% in the control group versus 35% in the reflux group (p<0.001).
Patients with reflux esophagitis and Barrett's esophagus have a significantly lower prevalence of H. pylori colonization than controls, in particular of the cagA(+) type. These data suggest that colonization with cagA(+) H. pylori strains may be protective against the development of GERD
检验携带细胞毒素相关基因A(cagA)阳性幽门螺杆菌菌株可预防胃食管反流病(GERD)及其并发症发生这一假说。
对反流性食管炎和巴雷特食管患者进行研究。获取胃窦活检标本以检测幽门螺杆菌。采集血清样本以测定幽门螺杆菌及CagA蛋白的IgG抗体。
共研究了736例患者。118例患有反流性食管炎,36例患有巴雷特食管,108例有食管裂孔疝但无炎症迹象(反流组),20例患有食管癌或胃癌。其余454例患者无GERD体征。262例反流性疾病患者的幽门螺杆菌感染率(34.9%)显著低于454例对照组患者(54.6%;p<0.001)。在310例有血清样本的幽门螺杆菌阳性患者中,对照组59%检测到携带cagA阳性菌株,而反流组为35%(p<0.001)。
反流性食管炎和巴雷特食管患者的幽门螺杆菌感染率,尤其是cagA阳性类型,显著低于对照组。这些数据表明,携带cagA阳性幽门螺杆菌菌株可能对GERD的发生具有保护作用